Regulatory Consulting Costs Adhere To Lifecore Long After Intergel Review
This article was originally published in The Gray Sheet
Executive Summary
Lifecore Biomedical expects to retain regulatory consultants for its Intergel adhesion prevention barrier solution during the first half of its 2002 fiscal year, which began July 1, pending a favorable outcome of FDA's Medical Devices Dispute Resolution Panel meeting on Sept. 6.